TENT5C and prostate cancer: Bioinformatics analysis based on the TCGA database showed that the transcript level of FAM46A, FAM46B and FAM46C, but not FAM46D, was decreased in prostate cancer tissues compared with noncancerous prostate tissues (Figure 1A).